Schedule of Investment in Sarborg Using Cost Method (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2026 |
|
| Defined Benefit Plan Disclosure [Line Items] | ||
| Balance as of December 31, 2025 | ||
| Balance as of June 30, 2026 | $ 122,846 | 122,846 |
| Sarborg Limited [Member] | ||
| Defined Benefit Plan Disclosure [Line Items] | ||
| Balance as of December 31, 2025 | 122,932 | |
| Investment in Sarborg | 123,000 | |
| Loss on equity investment in Sarborg | (86) | (154) |
| Impairment on equity investment in Sarborg | ||
| Balance as of June 30, 2026 | $ 122,846 | $ 122,846 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other-than-temporary decline in value that has been recognized against investment accounted for under equity method of accounting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow associated with the purchase of all investments (debt, security, other) during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|